BROS vs CPHI · P/E 105, rev $1.28B vs rev $4.1M
Dutch Bros Inc (BROS) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BROS revenue for 2024-12-31 was $1.28B. Net income was $66.5M. Revenue was up 32.6% from 2023-12-31 to 2024-12-31. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
BROS currently screens at market cap $11.74B and trailing P/E 105.0. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the BROS and CPHI stock pages for the full models.
Not investment advice.